Dr Sofia Bartlett

Adu P; Binka M; Mahmood B; Jeong D; Buller-Tylor T; Damascene MJ; Iyaniwura S; Ringa N; Velasquez H; Wong S; Yu A; Bartlett S; Wilton J; Irvine M; Otterstatter M; Janjua N, 2022, 'Quantifying Contact Patterns: Development and Characteristics of the British Columbia COVID-19 Population Mixing Patterns Survey', International Journal of Infectious Diseases, vol. 116, pp. S30 - S31, http://dx.doi.org/10.1016/j.ijid.2021.12.073

Pearce ME; Bartlett SR; Yu A; Lamb J; Reitz C; Wong S; Alvarez M; Binka M; Velásquez Garcia H; Jeong D; Clementi E; Adu P; Samji H; Wong J; Buxton J; Yoshida E; Elwood C; Sauve L; Pick N; Krajden M; Janjua NZ, 2021, 'Women in the 2019 hepatitis C cascade of care: findings from the British Columbia Hepatitis Testers cohort study', BMC Women's Health, vol. 21, http://dx.doi.org/10.1186/s12905-021-01470-7

Binka M; Bartlett S; Velásquez García HA; Darvishian M; Jeong D; Adu P; Alvarez M; Wong S; Yu A; Samji H; Krajden M; Wong J; Janjua NZ, 2021, 'Impact of COVID-19-related public health measures on HCV testing in British Columbia, Canada: An interrupted time series analysis', Liver International, vol. 41, pp. 2849 - 2856, http://dx.doi.org/10.1111/liv.15074

Cholette F; Mesa C; Harris A; Ellis H; Cachero K; Lacap P; Galipeau Y; Langlois MA; Gingras AC; Yansouni CP; Papenburg J; Cheng MP; Chakraborty P; Stein DR; Van Caeseele P; Bartlett S; Krajden M; Goldfarb D; McGeer A; Osiowy C; Hankins C; Mazer B; Drebot M; Kim J, 2021, 'Dried blood spot specimens for SARS-CoV-2 antibody testing: A multi-site, multi-assay comparison', PLoS ONE, vol. 16, http://dx.doi.org/10.1371/journal.pone.0261003

Janjua NZ; Wong S; Abdia Y; Jeong D; Buller-Taylor T; Adu PA; Samji H; Wilton J; Pearce M; Butt ZA; Yu A; Binka M; Bartlett S; Alvarez M; Krajden M, 2021, 'Impact of direct-acting antivirals for HCV on mortality in a large population-based cohort study', Journal of Hepatology, vol. 75, pp. 1049 - 1057, http://dx.doi.org/10.1016/j.jhep.2021.05.028

Kronfli N; Dussault C; Bartlett S; Fuchs D; Kaita K; Harland K; Martin B; Whitten-Nagle C; Cox J, 2021, 'Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination', CANADIAN LIVER JOURNAL, vol. 4, pp. 292 - 310, http://dx.doi.org/10.3138/canlivj-2020-0035

Gin S; Buxton J; Janjua NZ; Krajden M; Bartlett SR, 2021, 'Addressing inequities in care on the path to eliminating hepatitis C in BC', British Columbia Medical Journal, vol. 63, pp. 252

Jeong D; Karim ME; Wong S; Wilton J; Butt ZA; Binka M; Adu PA; Bartlett S; Pearce M; Clementi E; Yu A; Alvarez M; Samji H; Velásquez García HA; Abdia Y; Krajden M; Janjua NZ, 2021, 'Impact of HCV infection and ethnicity on incident type 2 diabetes: Findings from a large population-based cohort in British Columbia', BMJ Open Diabetes Research and Care, vol. 9, http://dx.doi.org/10.1136/bmjdrc-2021-002145

Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ, 2021, 'HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men', Liver International, vol. 41, pp. 482 - 493, http://dx.doi.org/10.1111/liv.14762

Bartlett SR; Buxton J; Palayew A; Picchio CA; Janjua NZ; Kronfli N, 2021, 'Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era', Clinical Liver Disease, vol. 17, pp. 75 - 80, http://dx.doi.org/10.1002/cld.1023

Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2021, '"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis', Journal of studies on alcohol and drugs, vol. 82, pp. 158 - 160, http://dx.doi.org/10.15288/jsad.2021.82.158

Samji H; Yu A; Wong S; Wilton J; Binka M; Alvarez M; Bartlett S; Pearce M; Adu P; Jeong D; Clementi E; Butt Z; Buxton J; Gilbert M; Krajden M; Janjua NZ, 2020, 'Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada', International Journal of Drug Policy, vol. 86, http://dx.doi.org/10.1016/j.drugpo.2020.102989

Pearce ME; Yu A; Alvarez M; Bartlett SR; Binka M; Jeong D; Clementi E; Adu P; Wilton J; Yoshida EM; Pick N; Buxton JA; Wong J; Jassem A; Krajden M; Janjua NZ, 2020, 'Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019', PLoS ONE, vol. 15, http://dx.doi.org/10.1371/journal.pone.0244575

Clementi E; Bartlett S; Otterstatter M; Buxton JA; Wong S; Yu A; Butt ZA; Wilton J; Pearce M; Jeong D; Binka M; Adu P; Alvarez M; Samji H; Abdia Y; Wong J; Krajden M; Janjua NZ, 2020, 'Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services', International Journal of Infectious Diseases, vol. 100, pp. 27 - 33, http://dx.doi.org/10.1016/j.ijid.2020.08.035

Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, vol. 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985

Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2020, 'Addressing the syndemic of hiv, hepatitis c, overdose, and covid-19 among people who use drugs: The potential roles for decriminalization and safe supply', Journal of Studies on Alcohol and Drugs, vol. 81, pp. 556 - 560, http://dx.doi.org/10.15288/jsad.2020.81.556

Wilton J; Wong S; Yu A; Ramji A; Cook D; Butt ZA; Alvarez M; Binka M; Darvishian M; Jeong D; Bartlett SR; Pearce ME; Adu PA; Yoshida EM; Krajden M; Janjua NZ, 2020, 'Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic Hepatitis C in British Columbia, Canada: A population-based cohort study', Open Forum Infectious Diseases, vol. 7, http://dx.doi.org/10.1093/ofid/ofaa055

Darvishian M; Wong S; Binka M; Yu A; Ramji A; Yoshida EM; Wong J; Rossi C; Butt ZA; Bartlett S; Pearce ME; Samji H; Cook D; Alvarez M; Chong M; Tyndall M; Krajden M; Janjua NZ, 2020, 'Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies', Journal of Viral Hepatitis, vol. 27, pp. 243 - 260, http://dx.doi.org/10.1111/jvh.13228

Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233

Janjua N; Wilton J; Cook D; Wong S; Butt Z; Bartlett S; Pearce DM; Ramji A; Yoshida E; Yu A; Alvarez M; Binka M; Krajden M, 2020, 'Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment', Journal of Hepatology, vol. 73, pp. S356 - S357, http://dx.doi.org/10.1016/s0168-8278(20)31209-5

Janjua N; Yu A; Wilton J; Adu P; Pearce DM; Samji H; McKee G; Bartlett S; Butt Z; Binka M; Abdia Y; Wong S; Jeong D; Clementi E; Alvarez M; Wong DJ; Krajden M, 2020, 'Population-level hepatitis C cascade of care among men who have sex with men in British Columbia, Canada', Journal of Hepatology, vol. 73, pp. S32 - S32, http://dx.doi.org/10.1016/s0168-8278(20)30617-6

Binka M; Abdia Y; Wilton J; Butt Z; Darvishian M; Wong S; Yu A; Bartlett S; Jeong D; Clementi E; Adu P; Pearce DM; Alvarez M; Yoshida E; Ramji A; Wong DJ; Krajden M; Janjua N, 2020, 'All-cause mortality and liver-related death following entecavir, tenofovir disoproxil fumarate or lamivudine therapy among treatment-naive chronic hepatitis B patients in British Columbia, Canada', Journal of Hepatology, vol. 73, pp. S875 - S876, http://dx.doi.org/10.1016/s0168-8278(20)32192-9

Clementi E; Bartlett S; Janjua N; Wong S; Yu A; Pearce DM; Binka M; Alvarez M; Jeong D; Wilton J; Adu P; Abdia Y; Wong DJ; Krajden M; Buxton J; Otterstatter M; Butt Z; McKee G, 2020, 'Classifying people living with hepatitis C virus using a population-level latent class analysis to inform optimal integration of health services', Journal of Hepatology, vol. 73, pp. S804 - S805, http://dx.doi.org/10.1016/s0168-8278(20)32053-5

Pearce DM; Yu A; Alvarez M; Bartlett S; Binka M; Jeong D; Clementi E; Jassem A; Yoshida E; Wong DJ; Pick N; Krajden M; Janjua N, 2020, 'Frequency of prenatal hepatitis C screening and diagnosis in British Columbia, 2008–2018', Journal of Hepatology, vol. 73, pp. S814 - S815, http://dx.doi.org/10.1016/s0168-8278(20)32071-7

Jeong D; Wong S; Karim ME; Binka M; Butt Z; Abdia Y; Adu P; Wilton J; Yu A; Alvarez M; Pearce DM; Bartlett S; Krajden M; Janjua N, 2020, 'Ethnic disparities in the risk of hepatitis C virus-related diabetes in a large population-based cohort in Canada', Journal of Hepatology, vol. 73, pp. S309 - S309, http://dx.doi.org/10.1016/s0168-8278(20)31120-x

Janjua N; Wong S; Wilton J; Adu P; Butt Z; Samji H; McKee G; Binka M; Abdia Y; Yu A; Bartlett S; Jeong D; Clementi E; Pearce DM; Alvarez M; Wong DJ; Krajden M, 2020, 'Incidence of HCV infection among gbMSM in British Columbia, Canada: a population-based cohort study', Journal of Hepatology, vol. 73, pp. S819 - S819, http://dx.doi.org/10.1016/s0168-8278(20)32080-8

Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ, 2019, 'The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals', Liver International, vol. 39, pp. 2261 - 2272, http://dx.doi.org/10.1111/liv.14227

Rossi C; Jeong D; Wong S; McKee G; Butt ZA; Buxton J; Wong J; Darvishian M; Bartlett S; Samji H; Yu A; Binka M; Alvarez M; Adu PA; Tyndall M; Krajden M; Janjua NZ, 2019, 'Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations', Journal of Hepatology, vol. 71, pp. 1116 - 1125, http://dx.doi.org/10.1016/j.jhep.2019.07.021

Bartlett S; Krajden M; Janjua N; Buller-Taylor T, 2019, 'Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums', British Columbia Medical Journal, vol. 61, pp. 78 - 80

Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, vol. 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222

Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthews G, 2019, 'SAT-235-Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', Journal of Hepatology, vol. 70, pp. e734 - e734, http://dx.doi.org/10.1016/s0618-8278(19)31468-9

Janjua N; Wong S; Rossi C; Darvishian M; Yu A; Butt ZA; Yoshida E; Ramji A; Feld J; Binka M; Bartlett S; Pearce DM; Alvarez M; Samji H; Tyndall M; Krajden M, 2019, 'SAT-238-The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort', Journal of Hepatology, vol. 70, pp. e736 - e736, http://dx.doi.org/10.1016/s0618-8278(19)31471-9

Bartlett SR; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Dore GJ; Russell DB, 2018, 'Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project', Clinical Infectious Diseases, vol. 67, pp. 460 - 463, http://dx.doi.org/10.1093/cid/ciy210

Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, vol. 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky JM; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of hepatitis C virus for detection of resistance to direct-acting antiviral therapy: A systematic review', Hepatology Communications, vol. 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050

Martinello M; Dore GJ; Bopage RI; Finlayson R; Baker D; Bloch M; Filep E; Skurowski J; Lin L; Lamoury F; Bartlett S; Applegate T; Hellard M; Matthews GV, 2017, 'O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy', Journal of Virus Eradication, vol. 3, pp. 3 - 3, http://dx.doi.org/10.1016/s2055-6640(20)30890-6

Bartlett SR; Applegate T; Jacka B; Lamoury F; Bull R; Danta M; Bradshaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2017, 'P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015', Journal of Virus Eradication, vol. 3, pp. 14 - 15, http://dx.doi.org/10.1016/s2055-6640(20)30747-0

Russell DB; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Bartlett S; Dore GJ, 2017, 'O16 A regional prison cleared of hepatitis C in less than 12 months', Journal of Virus Eradication, vol. 3, pp. 6 - 6, http://dx.doi.org/10.1016/s2055-6640(20)30899-2

Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028

Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437

Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003

Bartlett SR; Seeliger J; Burnell JN, 2012, 'Identification of critical residues in the bifunctional phosphoenolpyruvate synthetase kinase/phosphotransferase of Escherichia coli', Current Topics in Biochemical Research, vol. 14, pp. 77 - 83

Krajden M; Cook D; Wong S; Wilton J; Butt ZA; Bartlett S; Pearce M; Ramji A; Yoshida EM; Yu A; Alvarez MJ; Binka M; Janjua N, 2019, 'REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT', in HEPATOLOGY, WILEY, Boston, MA, pp. 914A - 914A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653503207&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Pearce M; Samji H; Bartlett S; Wong S; Yu A; Binka M; Alvarez MJ; Butt ZA; Ramji A; Yoshida EM; Krajden M; Janjua N, 2019, 'FACTORS ASSOCIATED WITH HCV TREATMENT INITIATION ACROSS ETHNIC GROUPS IN BRITISH COLUMBIA, CANADA: A POPULATION-BASED COHORT STUDY', in HEPATOLOGY, WILEY, Boston, MA, pp. 345A - 346A, presented at Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, Boston, MA, 08 November 2019 - 12 November 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000488653501115&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Darvishian M; Rossi C; Wong S; Yu A; Wong J; Buxton J; Gilbert M; Binka M; Butt Z; Bartlett S; Pearce M; Alvarez M; Cook D; Grennan T; Woods R; Spinelli J; Tyndall M; Krajden M; Janjua N, 2019, 'CANCER RISK AMONG PEOPLE WITH HIV, HBV AND/OR HCV INFECTIONS', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A190 - A191, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.481

Mckee G; Chapinal N; Butt Z; Rossi C; Wong S; Gilbert M; Wong J; Alvarez M; Darvishian M; Bartlett S; Pearce M; Samji H; Tyndall M; Krajden M; Janjua N, 2019, 'EVOLUTION OF HEPATITIS C CARE CASCADES AMONG HIV AND HEPATITIS B CO-INFECTED PATIENTS IN BRITISH COLUMBIA, CANADA', in SEXUALLY TRANSMITTED INFECTIONS, BMJ PUBLISHING GROUP, pp. A191 - A191, presented at Abstracts for the STI & HIV World Congress (Joint Meeting of the 23rd ISSTDR and 20th IUSTI), July 14–17, 2019, Vancouver, Canada, http://dx.doi.org/10.1136/sextrans-2019-sti.483

Darvishian M; Rossi C; Wong S; Yu A; Woods R; Binka M; Butt ZA; Buxton J; Bartlett S; Pearce M; Wong J; Gilbert M; Grennan T; Alvarez M; Cook D; Yoshida E; Spinelli J; Tyndall M; Krajden M; Janjua N, 2019, 'Cancer risk among people with HIV, HBV, and/or HCV infections', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E328 - E329, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30642-5

Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018

Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4